Therapeutic use monoclonal antibody rheumatoid arthritis patients severe rheumatoid arthritis murine monoclonal antibody open study mg/day mg/day mg/day consecutive days Tolerance excellent patients treatment Ritchie index morning stiffness scale C-reactive protein average reduction variables Day clinical benefit months patients significative depletion total lymphocyte positive cells treatment Evidence murine immunization patients 